Frier Levitt has recently become aware that the New Jersey Department of Health (NJDOH) has been issuing notices to medical practices and other facilities that may offer Platelet-Rich Plasma (PRP) injections to patients for non-surgical purposes –... Read More
All types of single and multi-specialty medical practice groups | Articles | Healthcare | Healthcare Law | Healthcare Litigation | Healthcare Practice Compliance | Physicians and Medical Practices of all Specialties

After DEA’s of its draft temporary rule last week, the Drug Enforcement Administration (“DEA”) has officially published a temporary rule expanding COVID-19 related flexibilities for prescribing controlled substances via telehealth. The... Read More
All types of single and multi-specialty medical practice groups | Articles | Behavioral Health Practitioners | Federal and State Fraud and Abuse Counseling | Healthcare Practice Compliance | Medical Practice Representation | Pain Management Compliance | Physicians and Medical Practices of all Specialties | Professional Practice Representation | Telehealth and Telemedicine | Telehealth and Telemedicine

Beginning in March 2020 with the shutdown orders effectuated by Governor Phil Murphy, the various licensing boards organized under the State of New Jersey, Division of Consumer Affairs, experienced a significant decrease in activity. The state was... Read More
All types of single and multi-specialty medical practice groups | Articles | Behavioral Health Practitioners | Dispensing Physician Practices and Dispensing Physicians | Federal and State Fraud and Abuse Counseling | Healthcare Practice Compliance | Medical Practice Representation | Physicians and Medical Practices of all Specialties | Professional Board Actions | Professional Practice Representation | White Collar Criminal Defense & Government Investigations | White Collar Defense and Government Investigation

Last month, HHS Office for Civil Rights (“OCR”) announced that its COVID-19 related enforcement discretion regarding the Health Insurance Portability and Accountability Act of 1996 (“HIPAA”) will end on May 11, 2023, coinciding with the... Read More
All types of single and multi-specialty medical practice groups | Articles | Behavioral Health Practitioners | Data Transactions | Healthcare Practice Compliance | HIPAA Compliance | Medical Practice Representation | Physicians and Medical Practices of all Specialties | Telehealth and Telemedicine | Telehealth and Telemedicine

Fraud is a persistent issue in the history of U.S. healthcare. However, with the government’s decreased oversight and the implementation of telehealth billing codes and diagnostic abilities during the COVID-19 pandemic, new opportunities for... Read More
Administrative and Insurance Defense Law | Articles | Healthcare Practice Compliance | Medicare and Insurance Audits | News | Professional Practice Representation

Last month, Cerebral, Inc., notified the Department of Health and Human Services Office for Civil Rights (“OCR”), and issued a public notice, that nearly 3.2 million individuals may have been affected by a breach of data, including protected... Read More
Articles | Data Transactions | Digital Pharmacies | Federal and State Fraud and Abuse Counseling | Federal and State Fraud and Abuse Counseling | Healthcare Practice Compliance | HIPAA Compliance | Management Services Organizations (MSO) | Regulatory Compliance, including FDA, DEA and HIPAA | Risk Assessment Mitigation Strategy | Telehealth and Telemedicine | Telehealth and Telemedicine

Frier Levitt attorneys speak with prosecutors, Boards of Pharmacies, PBM auditors, wholesalers, and the like on a daily basis on behalf of pharmacies nationally. We regularly spot trends and report back to the industry. We are closely monitoring... Read More
All types of single and multi-specialty medical practice groups | Articles | Behavioral Health Practitioners | Biotech Companies | Chain Pharmacies | Community, Retail Pharmacies | Data Transactions | Digital Pharmacies | Drug and Device Advertising, Marketing & Promotion Legal Review | Federal and State Fraud and Abuse Counseling | Federal and State Fraud and Abuse Counseling | Healthcare Practice Compliance | Manufacturers | Pharmaceutical Manufacturers | Pharmaceutical Wholesalers | Physicians and Medical Practices of all Specialties | Professional Practice Representation | Provider Relationship | Regulatory Compliance, including FDA, DEA and HIPAA | Telehealth and Telemedicine | Telehealth and Telemedicine | White Collar Criminal Defense & Government Investigations | White Collar Defense and Government Investigation

The healthcare and life science industries should be aware of the recent increase in False Claims Act (“FCA”) or “whistleblower” cases. In fiscal year 2022, the Department of Justice (“DOJ”) recovered $2.2 billion under the FCA. In 2021,... Read More
Articles | Federal and State Fraud and Abuse Counseling | Federal and State Fraud and Abuse Counseling | Healthcare Practice Compliance | Professional Practice Representation | White Collar Criminal Defense & Government Investigations | White Collar Defense and Government Investigation

In the wake of the Federal Trade Commission (“FTC”) enforcement action against GoodRx last month, the agency has issued another proposed consent order against virtual mental health platform BetterHelp on a similar basis. Namely, the... Read More
Articles | Behavioral Health Practitioners | Data Transactions | Federal and State Fraud and Abuse Counseling | Healthcare Practice Compliance | HIPAA Compliance